Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial.
about
Coming safely to a stop: a review of platelet activity after cessation of antiplatelet drugsHighlights of the year in JACC 2012Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgeryAntiplatelet drug interactions with proton pump inhibitorsGradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication.Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementationAdvances in platelet function testing assessing bleeding complications in patients with coronary artery disease.Platelet function monitoring and clopidogrel.Antiplatelet therapy: new pharmacological agents and changing paradigms.Cangrelor: a review on pharmacology and clinical trial development.Bridging antiplatelet therapy in patients requiring cardiac and non-cardiac surgery: from bench to bedside.Cangrelor for treatment of arterial thrombosis.Pharmacokinetic evaluation of prasugrel for the treatment of myocardial infarction.Novel antiplatelet agents in acute coronary syndrome.Prasugrel hydrochloride for the treatment of acute coronary syndromes.Role of Genetic Testing in Patients undergoing Percutaneous Coronary Intervention.The future of P2Y12 receptor antagonists.P2Y12 antagonists in non-ST-segment elevation acute coronary syndromes: latest evidence and optimal useSwitching P2Y12-receptor inhibitors in patients with coronary artery disease.A New Generation of Antiplatelet, and Anticoagulant Medication and the Implications for the Dental Surgeon.Cangrelor for treatment during percutaneous coronary intervention.The Role of Platelet Function Analyzer Testing in Cardiac Surgery Transfusion Management.Update on pharmacological treatment of acute coronary syndrome without persistent ST segment elevation myocardial infarction in the elderlyLegacy of blood: does prasugrel inhibit megakaryocytes and do juvenile platelets inherit this inhibition?Conversations in cardiology: bridging antiplatelet therapy before surgery.Clopidogrel Therapy in Patients with Cardiovascular Disease Undergoing Transurethral Resection of the Prostate: A Step Towards Individualization.Perioperative changes in platelet count and function in patients undergoing cardiac surgery.Antiplatelet Therapy for Non-ST-Segment Elevation Myocardial Infarction in Complex "Real" Clinical Scenarios: A Consensus Document of the "Campania NSTEMI Study Group".Platelet function recovery after ticagrelor withdrawal in patients awaiting urgent coronary surgery.Platelet function testing in contemporary clinical and interventional practice.
P2860
Q26795403-07A4C4A0-5EBE-49FE-A70D-551C57DB21BFQ26865608-8DC1649C-710D-4C49-8B88-C9F6CA5E44FFQ33755419-3C1365A2-4E62-4E2D-BF28-74D6CECF0BBBQ33948811-7ADC680E-B43B-4DB2-8B33-36871587568EQ36709028-7E09DC0E-DD4F-46B1-B56B-C95A82169450Q36715385-97617F09-3CF0-4B7A-BB6A-CA77C365D284Q38027576-F2538153-8A75-4363-9AA0-138531EC387CQ38068348-89E3DD86-D36E-4876-9F11-16C4202C2D49Q38117743-653D19D1-B2E9-4B8B-957D-CD37F50AB860Q38153779-7D31517F-C619-4A22-A9A0-5FD9AFBCC2DFQ38165873-72C7BED6-A0C3-4C7F-8542-4DA4C9DECCFEQ38183489-769A5AE1-67FD-4751-92B9-58CE3318AF5FQ38189810-92738B1D-07F7-485F-8CBD-38BCED417837Q38257119-B904D217-D18D-493C-9E5B-759006F9473FQ38336838-85D56C7C-36FF-4F4C-8EAF-3D4D179B9DD2Q38401281-0F4BD88E-B3EA-4939-8C01-AD676F4B09BFQ38515684-B858F396-3E2A-415F-8F33-1DFC368BC4F9Q38542096-6CAB0B30-3DDE-4DD9-9A87-E9860289A9BFQ38568711-5D428B5B-FA9E-4954-89E8-D48151F8E8B3Q38691618-D63B0F77-AEF7-45E2-8B87-99DBA8EE055CQ39204251-B9BDEDD6-417E-4754-9FB1-6558A732A016Q40201873-D43F74A0-8CF7-4A7B-B166-9C07F88E0E30Q41265471-0240A159-F57B-4621-B194-E7BF4B5B3B3EQ42943364-4507729F-7E7B-46E3-88BD-46CBF9D5E24CQ45954086-5584FCEC-CC08-4908-89F2-4036F9A4DC3AQ48234237-10FE0923-6898-4C90-91F5-3C09B0FE98D0Q49314452-21017423-2E51-4237-8065-BE061DE0061CQ50864337-7E0707DF-83A2-43AD-B004-89DB480F8593Q50994122-B12EFDB0-20C0-4933-A3CF-9650177DBBDAQ51746988-12C6CB10-4CE0-4860-8E58-1838EB5C3988
P2860
Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Recovery of platelet function ...... y disease: the recovery trial.
@ast
Recovery of platelet function ...... y disease: the recovery trial.
@en
Recovery of platelet function ...... y disease: the recovery trial.
@nl
type
label
Recovery of platelet function ...... y disease: the recovery trial.
@ast
Recovery of platelet function ...... y disease: the recovery trial.
@en
Recovery of platelet function ...... y disease: the recovery trial.
@nl
prefLabel
Recovery of platelet function ...... y disease: the recovery trial.
@ast
Recovery of platelet function ...... y disease: the recovery trial.
@en
Recovery of platelet function ...... y disease: the recovery trial.
@nl
P2093
P921
P1476
Recovery of platelet function ...... y disease: the recovery trial.
@en
P2093
Brian A Baker
Darell E Heiselman
Dominick J Angiolillo
Douglas K Logan
James S Walder
Joseph A Jakubowski
Kenneth J Winters
Matthew J Price
P304
P356
10.1016/J.JACC.2012.02.042
P407
P577
2012-06-01T00:00:00Z